drugset / Trial / NCT06722430
A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants
NaSingle-groupOpen-labelBasic science
Summary
This study is to assess the change of itraconazole, a strong CYP3A inhibitor, on the pharmacokinetics, safety, and tolerability of a single dose of icalcaprant in healthy participants.
Timeline
- Start
- 2024-11-13
- Primary completion
- 2025-01-13
- Completion
- 2025-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icalcaprant | Small molecule | — | Oral |
| Background | Itraconazole | Small molecule | — | Oral |
Indications
No indication recorded.